Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,002 | 459 | 99.5% |
| Education | $44.80 | 3 | 0.5% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,071 | 125 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,020 | 56 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $927.29 | 41 | $0 (2024) |
| UCB, Inc. | $714.94 | 29 | $0 (2019) |
| Janssen Biotech, Inc. | $639.26 | 37 | $0 (2024) |
| PFIZER INC. | $493.75 | 17 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $352.82 | 17 | $0 (2017) |
| Allergan, Inc. | $230.42 | 14 | $0 (2020) |
| Lilly USA, LLC | $215.56 | 6 | $0 (2024) |
| Celgene Corporation | $201.87 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,877 | 85 | ABBVIE INC. ($499.81) |
| 2023 | $1,248 | 62 | AbbVie Inc. ($226.78) |
| 2022 | $404.74 | 24 | ABBVIE INC. ($149.50) |
| 2021 | $71.92 | 3 | AbbVie Inc. ($29.99) |
| 2020 | $212.90 | 13 | Takeda Pharmaceuticals U.S.A., Inc. ($45.78) |
| 2019 | $1,896 | 96 | Takeda Pharmaceuticals U.S.A., Inc. ($480.64) |
| 2018 | $1,705 | 99 | AbbVie, Inc. ($499.54) |
| 2017 | $1,631 | 82 | UCB, Inc. ($366.42) |
All Payment Transactions
464 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $44.96 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/03/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Immunology | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Lilly USA, LLC | OMVOH (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Immunology | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 366 | 7,319 | $452,563 | $160,933 |
| 2022 | 12 | 424 | 501 | $287,704 | $50,318 |
| 2021 | 11 | 361 | 436 | $207,557 | $44,053 |
| 2020 | 11 | 400 | 469 | $202,353 | $44,971 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 11 | 6,900 | $189,750 | $117,165 | 61.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 42 | 42 | $60,845 | $8,429 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 79 | $20,044 | $7,398 | 36.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 48 | 48 | $56,496 | $5,950 | 10.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 28 | 29 | $30,146 | $5,342 | 17.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 40 | $12,320 | $4,286 | 34.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 53 | 53 | $43,434 | $4,130 | 9.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 17 | 17 | $17,672 | $3,279 | 18.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 22 | $3,388 | $1,456 | 43.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 25 | $11,000 | $1,405 | 12.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,740 | $1,338 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $2,057 | $734.08 | 35.7% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 16 | 38 | $1,672 | $19.39 | 1.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 97 | $24,242 | $9,639 | 39.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 43 | 43 | $61,504 | $8,903 | 14.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 59 | 59 | $68,587 | $8,368 | 12.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 75 | 76 | $61,612 | $6,553 | 10.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 54 | 55 | $16,660 | $6,028 | 36.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 50 | $7,616 | $2,879 | 37.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 13 | 13 | $13,325 | $2,454 | 18.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $17,483 | $2,350 | 13.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 14 | 22 | $9,600 | $1,335 | 13.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 14 | $2,516 | $894.93 | 35.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,633 | $891.82 | 33.9% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2022 | 21 | 44 | $1,928 | $23.20 | 1.2% |
About Dr. Michelle Smedley, MD
Dr. Michelle Smedley, MD is a Gastroenterology healthcare provider based in Farmington, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891899415.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Smedley, MD has received a total of $9,046 in payments from pharmaceutical and medical device companies, with $1,877 received in 2024. These payments were reported across 464 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($9,002).
As a Medicare-enrolled provider, Smedley has provided services to 1,551 Medicare beneficiaries, totaling 8,725 services with total Medicare billing of $300,274. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Farmington, CT
- Active Since 09/12/2006
- Last Updated 05/03/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1891899415
Products in Payments
- Humira (Biological) $965.11
- Entyvio (Biological) $792.31
- XIFAXAN (Drug) $791.86
- Cimzia (Drug) $590.09
- STELARA (Biological) $509.82
- RINVOQ (Biological) $446.73
- ENTYVIO (Biological) $373.18
- DUPIXENT (Biological) $310.19
- SKYRIZI (Biological) $245.03
- OMVOH (Drug) $215.56
- LINZESS (Drug) $208.60
- VIBERZI (Drug) $201.03
- REMICADE (Biological) $199.29
- XIFAXANIBSD (Drug) $193.54
- ZEPOSIA (Drug) $187.19
- XELJANZ (Drug) $178.85
- OCALIVA (Drug) $152.19
- Creon (Drug) $140.13
- VOQUEZNA (Drug) $138.40
- GATTEX (Drug) $133.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Farmington
James Freston, M.d, M.D
Gastroenterology — Payments: $1.2M
Houman Rezaizadeh, M.d, M.D
Gastroenterology — Payments: $65,272
Dr. Neil Parikh, M.d, M.D
Gastroenterology — Payments: $39,683
Dr. John Birk, M.d, M.D
Gastroenterology — Payments: $13,329
George Wu, Md, MD
Gastroenterology — Payments: $11,476
Jolian Kathawa, D.o, D.O
Gastroenterology — Payments: $6,928